Literature DB >> 8362531

Exogenous growth hormone: effects on the catabolic response to surgically produced acute stress and on postoperative immune function.

R Vara-Thorbeck1, J A Guerrero, J Rosell, E Ruiz-Requena, J M Capitán.   

Abstract

The first purpose of the present prospective randomized study was to determine if the protein catabolic response after operation could be restrained by administration of hypocaloric parenteral nutrition (HPN) plus human growth hormone (hGH). Our second aim was to determine if the administration of hGH could improve the systemic host defenses, thereby reducing the risk of infection. We performed a placebo-controlled randomized double-blind trial in 180 patients after elective cholecystectomy with or without choledochoduodenostomy (placebo = control group, n = 93; hGH-treated group, n = 87). The results obtained in this study show that positive nitrogen balance can be achieved during the postoperative period from the first 24 hours onward, with a combination of HPN support (1.0-1.5 g protein/kg/day and 900 kcal/day) together with the administration of small doses (8 IU) of hGH. The potassium balance tended to follow the same positive balance as the nitrogen balance. Our study shows that in the control group, treated only with HPN, a significant decrease in serum levels of some acute-phase proteins (retinol-binding protein, transferrin, prealbumin), albumin, total proteins, and immunoglobulins occurs by the 5th postoperative day. In the GH group the values of all the above-mentioned proteins do not change or tend to rise if compared to preoperative levels. In the GH-treated group liver function appeared to improve at the start of the study. GH and somatomedin C levels were similar in the two groups and had not changed significantly in the control group by the 5th postoperative day.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8362531     DOI: 10.1007/bf01655116

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  31 in total

Review 1.  Metabolic response to sepsis and trauma.

Authors:  R G Douglas; J H Shaw
Journal:  Br J Surg       Date:  1989-02       Impact factor: 6.939

2.  Positive nitrogen balance with human growth hormone and hypocaloric intravenous feeding.

Authors:  J M Manson; D W Wilmore
Journal:  Surgery       Date:  1986-08       Impact factor: 3.982

3.  Avoiding autocannibalism.

Authors:  R J Ross; J P Miell; C R Buchanan
Journal:  BMJ       Date:  1991-11-09

4.  The gut origin septic states in blunt multiple trauma (ISS = 40) in the ICU.

Authors:  J R Border; J Hassett; J LaDuca; R Seibel; S Steinberg; B Mills; P Losi; D Border
Journal:  Ann Surg       Date:  1987-10       Impact factor: 12.969

5.  Predicting surgical infection before the operation.

Authors:  J L Meakins; J B Pietsch; N V Christou; L D Maclean
Journal:  World J Surg       Date:  1980-07       Impact factor: 3.352

6.  Small-bowel bacterial overgrowth and systemic immunosuppression in experimental peritonitis.

Authors:  J C Marshall; N V Christou; J L Meakins
Journal:  Surgery       Date:  1988-08       Impact factor: 3.982

7.  Effects of recombinant human growth hormone on donor-site healing in severely burned children.

Authors:  D N Herndon; R E Barrow; K R Kunkel; L Broemeling; R L Rutan
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

8.  Effects of human growth hormone in men over 60 years old.

Authors:  D Rudman; A G Feller; H S Nagraj; G A Gergans; P Y Lalitha; A F Goldberg; R A Schlenker; L Cohn; I W Rudman; D E Mattson
Journal:  N Engl J Med       Date:  1990-07-05       Impact factor: 91.245

Review 9.  Nutrition, somatomedins, and the brain.

Authors:  L S Phillips
Journal:  Metabolism       Date:  1986-01       Impact factor: 8.694

10.  Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery.

Authors:  H C Ward; D Halliday; A J Sim
Journal:  Ann Surg       Date:  1987-07       Impact factor: 12.969

View more
  12 in total

1.  GH/IGF-I axis in severe systemic disorders.

Authors:  P De Feo
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

2.  Effects of short-term application of low-dose growth hormone on trace element metabolism and blood glucose in surgical patients.

Authors:  Kun Qian; Zhi Wan; Lang-Song Hao; Ming-Ming Zhang; Yong Zhou; Xiao-Ting Wu
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

3.  Clinical evidence of growth hormone for patients undergoing abdominal surgery: meta-analysis of randomized controlled trials.

Authors:  Yong Zhou; Xiao-Ting Wu; Gang Yang; Wen Zhuang; Mao-Ling Wei
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

4.  Expression of growth hormone receptor and its mRNA in hepatic cirrhosis.

Authors:  Hong-Tao Wang; Shuang Chen; Jie Wang; Qing-Jia Ou; Chao Liu; Shu-Sen Zheng; Mei-Hai Deng; Xiao-Ping Liu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

Review 5.  A risk-benefit assessment of growth hormone use in children.

Authors:  S L Blethen; M H MacGillivray
Journal:  Drug Saf       Date:  1997-11       Impact factor: 5.606

6.  Effects of human recombinant growth hormone (rhGH) on inflammatory responses in patients undergoing abdominal aortic aneurysm repair.

Authors:  K Mealy; M Barry; L O'Mahony; S Sheehan; P Burke; C McCormack; A S Whitehead; D Bouchier-Hayes
Journal:  Intensive Care Med       Date:  1998-02       Impact factor: 17.440

7.  Perioperative growth hormone treatment and functional outcome after major abdominal surgery: a randomized, double-blind, controlled study.

Authors:  P Kissmeyer-Nielsen; M B Jensen; S Laurberg
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

8.  Protective effects of recombinant human growth hormone on cirrhotic rats.

Authors:  Shuang Chen; Hong-Tao Wang; Bin Yang; Yu-Ru Fu; Qing-Jia Ou
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

9.  Effects of recombinant human growth hormone on enterocutaneous fistula patients.

Authors:  Guo-Sheng Gu; Jian-An Ren; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

10.  Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns.

Authors:  D N Herndon; H K Hawkins; T T Nguyen; E Pierre; R Cox; R E Barrow
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.